TFX - Teleflex Inc Stock Price, Fair Value and News

210.56USD-3.88 (-1.81%)Market Closed

Market Summary

USD210.56-3.88

Market Closed

-1.81%

TFX Stock Price

View Fullscreen

TFX RSI Chart

TFX Valuation

Market Cap

9.9B

Price/Earnings (Trailing)

27.81

Price/Sales (Trailing)

3.33

EV/EBITDA

19.43

Price/Free Cashflow

23.58

TFX Price/Sales (Trailing)

TFX Profitability

EBT Margin

14.59%

Return on Equity

8.02%

Return on Assets

4.73%

Free Cashflow Yield

4.24%

TFX Fundamentals

TFX Revenue

Revenue (TTM)

3.0B

Rev. Growth (Yr)

2.1%

Rev. Growth (Qtr)

3.69%

TFX Earnings

Earnings (TTM)

356.3M

Earnings Growth (Yr)

-60.42%

Earnings Growth (Qtr)

-77.32%

Breaking Down TFX Revenue

Last 7 days

-2.9%

Last 30 days

-2.2%

Last 90 days

-14.4%

Trailing 12 Months

-20.2%

How does TFX drawdown profile look like?

TFX Financial Health

Current Ratio

2.32

Debt/Equity

0.39

Debt/Cashflow

0.3

TFX Investor Care

Dividend Yield

0.65%

Dividend/Share (TTM)

1.36

Shares Dilution (1Y)

0.24%

Diluted EPS (TTM)

7.53

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	2.9B	2.9B	3.0B	3.0B
2022	2.8B	2.8B	2.8B	2.8B
2021	2.5B	2.7B	2.8B	2.8B
2020	2.6B	2.5B	2.5B	2.5B
2019	2.5B	2.5B	2.6B	2.6B
2018	2.2B	2.3B	2.4B	2.4B
2017	1.9B	2.0B	2.1B	2.1B
2016	1.8B	1.8B	1.8B	1.9B
2015	1.8B	1.8B	1.8B	1.8B
2014	1.7B	1.8B	1.8B	1.8B
2013	1.6B	1.6B	1.7B	1.7B
2012	1.5B	1.5B	1.5B	1.6B
2011	1.4B	1.5B	1.5B	1.5B
2010	1.4B	1.3B	1.2B	1.4B
2009	0	1.6B	1.5B	1.4B
2008	0	0	0	1.6B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Teleflex Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 05, 2024	hicks cameron p	sold	-1,665,220	225	-7,401	corp. vp & chief hr officer
Mar 05, 2024	hicks cameron p	acquired	1,000,200	135	7,401	corp. vp & chief hr officer
Mar 02, 2024	deren john	sold (taxes)	-30,551	223	-137	corp. vp & cao
Mar 02, 2024	hicks cameron p	sold (taxes)	-48,600	225	-216	corp. vp & chief hr officer
Mar 02, 2024	logue daniel v.	sold (taxes)	-33,227	223	-149	cvp, general counsel & secty
Mar 02, 2024	kelly liam	sold (taxes)	-410,320	223	-1,840	chairman, president & ceo
Mar 02, 2024	winters james	sold (taxes)	-68,015	223	-305	corp vp, mfg and supply
Mar 02, 2024	white jay	sold (taxes)	-53,297	223	-239	cvp & pres, global commercial
Mar 02, 2024	powell thomas e	sold (taxes)	-180,630	223	-810	executive vice president & cfo
Feb 27, 2024	white jay	acquired	-	-	1,356	cvp & pres, global commercial

Which funds bought or sold TFX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 12, 2024	Riverview Trust Co	new	-	30,759	30,759	0.02%
Apr 12, 2024	NORTHWEST INVESTMENT COUNSELORS, LLC	new	-	9,951	9,951	-%
Apr 12, 2024	GATEWAY INVESTMENT ADVISERS LLC	unchanged	-	-55,677	543,487	0.01%
Apr 12, 2024	STEPH & CO	added	124	85,536	167,818	0.06%
Apr 12, 2024	BALDWIN BROTHERS LLC/MA	unchanged	-	-141,337	1,379,640	0.10%
Apr 12, 2024	DNB Asset Management AS	new	-	1,630,230	1,630,230	0.01%
Apr 12, 2024	AdvisorNet Financial, Inc	reduced	-30.00	-910	1,583	-%
Apr 12, 2024	WASHINGTON CAPITAL MANAGEMENT, INC	added	15.91	28,186	576,734	0.47%
Apr 11, 2024	Opal Wealth Advisors, LLC	new	-	141,583	141,583	0.05%
Apr 11, 2024	CONGRESS ASSET MANAGEMENT CO /MA	reduced	-50.37	-737,752	604,100	-%

Are Funds Buying or Selling TFX?

Are funds buying TFX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own TFX

No. of Funds

Unveiling Teleflex Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	t. rowe price investment management, inc.	15.0%	7,039,991	SC 13G/A
Feb 13, 2024	janus henderson group plc	10.3%	4,828,005	SC 13G/A
Feb 13, 2024	vanguard group inc	11.61%	5,454,016	SC 13G/A
Feb 09, 2024	morgan stanley	5.5%	2,588,653	SC 13G/A
Feb 08, 2024	wellington management group llp	5.31%	2,496,566	SC 13G/A
Jan 24, 2024	blackrock inc.	9.1%	4,287,778	SC 13G/A
Dec 07, 2023	janus henderson group plc	10.3%	4,827,775	SC 13G
Feb 14, 2023	t. rowe price investment management, inc.	18.4%	8,633,473	SC 13G/A
Feb 10, 2023	morgan stanley	5.4%	2,525,191	SC 13G
Feb 09, 2023	vanguard group inc	11.56%	5,420,563	SC 13G/A

Recent SEC filings of Teleflex Inc

View All Filings

Date Filed	Form Type	Document
Apr 05, 2024	ARS	ARS
Apr 01, 2024	DEF 14A	DEF 14A
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 01, 2024	144	Notice of Insider Sale Intent

Peers (Alternatives to Teleflex Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	188.9B	40.1B	-5.73%	4.72%	33.01	4.71	-8.12%	-17.45%
BDX	67.8B	19.5B	-0.88%	-8.17%	53.97	3.48	4.02%	-22.04%
ALGN	22.9B	3.9B	-3.10%	-11.00%	51.41	5.92	3.42%	23.09%
BAX	20.3B	14.8B	-3.77%	-6.99%	7.66	1.37	2.12%	209.17%
MID-CAP
ATR	9.1B	3.5B	-1.99%	15.94%	32.07	2.62	4.97%	18.89%
HSIC	9.1B	12.3B	-5.16%	-14.19%	21.85	0.74	-2.44%	-22.68%
BIO	8.8B	2.7B	-9.88%	-37.29%	-13.77	3.29	-4.68%	82.43%
XRAY	6.4B	4.0B	-5.94%	-24.93%	-47.62	1.62	1.10%	85.84%
AXNX	3.4B	366.4M	-0.71%	17.46%	-565.84	9.37	33.86%	89.83%
PDCO	2.3B	6.6B	-6.94%	-4.63%	11.73	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-3.79%	-17.24%	-1.94	0.41	7.73%	-1066.14%
ANIK	376.4M	166.7M	-0.35%	-8.55%	-4.55	2.26	6.67%	-456.34%
ANGO	253.5M	324.0M	17.88%	-30.36%	-1.32	0.78	-3.19%	-337.41%
APYX	47.8M	52.3M	-22.91%	-54.00%	-2.55	0.91	17.61%	19.28%
AEMD	3.8M	3.7M	-16.18%	262.50%	-0.31	1.01	5.77%	8.23%

Teleflex Inc News

Latest updates

Teleflex Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	3.7%	774	746	743	711	758	687	705	642	762	700	713	634	711	628	567	631	681	648	653	614	642
Gross Profit	3.6%	431	416	408	391	422	374	389	346	420	388	398	345	384	329	278	334	378	355	352	324	366
S&GA Expenses	22.3%	261	213	223	233	233	210	217	204	228	205	224	203	233	172	191	148	220	209	216	207	137
R&D Expenses	-4.6%	36.00	38.00	39.00	41.00	43.00	38.00	37.00	36.00	36.00	32.00	33.00	30.00	34.00	29.00	29.00	27.00	31.00	28.00	28.00	27.00	28.00
EBITDA Margin	-7.6%	0.20*	0.21*	0.20*	0.20*	0.20*	0.21*	0.25*	0.24*	0.24*	0.23*	0.19*	0.17*	-	-	-	-	-	-	-	-	-
Interest Expenses	11.2%	26.00	23.00	18.00	18.00	19.00	13.00	11.00	10.00	12.00	12.00	16.00	17.00	19.00	17.00	16.00	15.00	17.00	20.00	21.00	23.00	23.00
Income Taxes	141.2%	29.00	12.00	16.00	20.00	31.00	17.00	18.00	16.00	16.00	30.00	16.00	12.00	-0.04	-0.95	12.00	11.00	-6.51	-130	4.00	11.00	9.00
Earnings Before Taxes	-59.9%	60.00	150	127	97.00	109	119	124	93.00	143	229	100	87.00	77.00	116	23.00	142	101	99.00	87.00	53.00	96.00
EBT Margin	-10.7%	0.15*	0.16*	0.16*	0.16*	0.16*	0.17*	0.21*	0.20*	0.20*	0.18*	0.14*	0.12*	-	-	-	-	-	-	-	-	-
Net Income	-77.3%	31.00	137	111	77.00	79.00	102	106	77.00	128	199	83.00	75.00	76.00	117	11.00	131	108	229	83.00	41.00	91.00
Net Income Margin	-12.2%	0.12*	0.14*	0.13*	0.13*	0.13*	0.15*	0.18*	0.17*	0.17*	0.16*	0.13*	0.11*	-	-	-	-	-	-	-	-	-
Free Cashflow	-37.0%	112	177	69.00	63.00	72.00	122	20.00	49.00	182	170	137	92.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	0.5%	7,533	7,494	6,896	6,918	6,928	6,758	6,732	6,873	6,872	7,040	7,066	7,028	7,153	6,613	6,765	6,702	6,310	6,257	6,314	6,268	6,278
Current Assets	-32.9%	1,407	2,097	1,446	1,428	1,411	1,459	1,385	1,494	1,429	1,542	1,437	1,379	1,422	1,421	1,545	1,447	1,306	1,238	1,245	1,183	1,236
Cash Equivalents	-74.7%	223	881	251	264	292	397	308	467	445	481	362	325	376	347	554	406	301	258	304	271	357
Inventory	0.2%	626	625	632	614	579	530	511	491	478	484	490	512	513	526	515	489	477	473	461	446	428
Net PPE	3.3%	480	464	465	459	447	422	429	436	444	446	450	468	474	445	432	427	431	430	425	410	433
Goodwill	716.2%	2,914	357	2,546	2,548	2,537	71.00	2,461	2,493	2,504	2,523	2,537	2,566	2,586	2,364	2,344	2,332	2,245	2,231	2,250	2,248	2,247
Liabilities	-2.8%	3,092	3,180	2,681	2,808	2,906	2,863	2,879	3,078	3,117	3,382	3,600	3,652	3,816	3,377	3,668	3,629	3,331	3,404	3,650	3,698	3,738
Current Liabilities	3.6%	607	585	555	576	581	611	610	656	680	562	527	508	540	475	457	402	563	530	494	521	582
Long Term Debt	-11.4%	1,728	1,950	1,471	1,549	1,624	1,594	1,606	1,741	1,740	1,949	2,216	2,295	2,378	2,036	2,329	2,341	1,859	1,949	2,081	2,073	2,072
LT Debt, Non Current	-11.4%	1,728	1,950	1,471	1,549	1,624	1,594	1,606	1,741	1,740	1,949	2,216	2,295	2,378	2,036	2,329	2,341	1,859	1,949	2,081	2,073	2,072
Shareholder's Equity	2.9%	4,441	4,314	4,215	4,110	4,022	3,895	3,853	3,796	3,755	3,658	3,466	3,376	3,336	3,236	3,097	3,073	2,979	2,853	2,665	2,570	2,540
Retained Earnings	-	4,110	-	-	-	3,817	-	-	-	3,518	-	-	-	3,096	-	-	-	2,825	-	-	-	2,428
Additional Paid-In Capital	-	750	-	-	-	715	-	-	-	693	-	-	-	652	-	-	-	617	-	-	-	575
Shares Outstanding	0.0%	47.00	47.00	47.00	47.00	47.00	47.00	47.00	47.00	47.00	47.00	47.00	47.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	5,634	-	-	-	6,991	-	-	-	11,995	-	-	-	10,306	-	-	-	9,090	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-30.9%	139,322	201,743	86,269	84,349	98,391	142,556	39,757	62,102	201,679	185,385	154,281	110,794	195,655	107,479	145,466	-11,457	147,901	131,883	97,118	60,166	132,142
Share Based Compensation	15.0%	9,330	8,115	7,005	7,015	7,420	7,003	7,499	5,302	5,872	5,372	6,349	5,344	5,980	6,277	4,960	3,522	6,903	7,337	6,919	5,781	5,969
Cashflow From Investing	-1879.4%	-563,530	-28,470	-7,329	-21,899	-202,202	-12,636	-31,756	-12,816	-10,989	199,482	-10,879	-20,877	-518,957	-24,265	-10,117	-284,444	116	-25,973	-24,096	-23,528	-118,093
Cashflow From Financing	-151.4%	-237,501	462,031	-92,399	-93,591	-17,133	-25,603	-153,810	-20,960	-215,407	-259,698	-109,221	-131,496	338,945	-296,218	7,106	405,330	-108,309	-142,878	-43,288	-124,361	-6,733
Dividend Payments	0.0%	15,977	15,978	15,972	15,969	15,949	15,948	15,946	15,946	15,932	15,923	15,900	15,893	15,837	15,826	15,791	15,767	15,757	15,724	15,697	15,650	15,639

TFX Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net revenues	$ 2,974,489	$ 2,791,041	$ 2,809,563
Cost of goods sold	1,327,558	1,259,954	1,259,961
Gross profit	1,646,931	1,531,087	1,549,602
Selling, general and administrative expenses	929,867	863,748	860,085
Research and development expenses	154,351	153,819	130,841
Settlements	45,244	0	0
Restructuring and impairment charges	15,604	20,299	21,738
Gain on sale of assets and business	(4,448)	(6,504)	(91,157)
Income from continuing operations before interest, loss on extinguishment of debt and taxes	506,313	499,725	628,095
Interest expense	85,082	54,264	56,969
Interest income	(12,781)	(912)	(1,328)
Loss on extinguishment of debt	0	454	12,986
Income from continuing operations before taxes	434,012	445,919	559,468
Taxes on income from continuing operations	76,440	83,003	74,349
Income from continuing operations	357,572	362,916	485,119
Operating (loss) income from discontinued operations	(1,608)	260	331
(Benefit) taxes on operating loss from discontinued operations	(364)	37	76
(Loss) income from discontinued operations	(1,244)	223	255
Net income	$ 356,328	$ 363,139	$ 485,374
Basic:
Income from continuing operations (in dollars per share)	$ 7.61	$ 7.74	$ 10.37
Income (loss) from discontinued operations (in dollars per share)	(0.03)	0	0.01
Net income (in dollars per share)	7.58	7.74	10.38
Diluted:
Income from continuing operations (in dollars per share)	7.56	7.67	10.23
Income (loss) from discontinued operations (in dollars per share)	(0.03)	0.01	0
Net income (loss), diluted (in dollar per share)	$ 7.53	$ 7.68	$ 10.23
Weighted average shares outstanding:
Basic (in shares)	46,981	46,898	46,774
Diluted (in shares)	47,304	47,309	47,427

TFX Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 222,848	$ 292,034
Accounts receivable, net	443,467	408,834
Inventories	626,216	578,507
Prepaid expenses and other current assets	107,471	125,084
Prepaid taxes	7,404	6,524
Total current assets	1,407,406	1,410,983
Property, plant and equipment, net	479,913	447,205
Operating lease assets	123,521	131,211
Goodwill	2,914,055	2,536,730
Intangibles assets, net	2,501,960	2,306,165
Deferred tax assets	6,748	6,402
Other assets	98,943	89,367
Total assets	7,532,546	6,928,063
Current liabilities
Current borrowings	87,500	87,500
Accounts payable	132,247	126,807
Accrued expenses	146,880	140,644
Payroll and benefit-related liabilities	146,535	133,092
Accrued interest	5,583	5,332
Income taxes payable	41,453	24,736
Other current liabilities	46,547	63,381
Total current liabilities	606,745	581,492
Long-term borrowings	1,727,572	1,624,023
Deferred tax liabilities	456,080	388,886
Pension and postretirement benefit liabilities	23,989	31,394
Noncurrent liability for uncertain tax positions	3,370	5,805
Noncurrent operating lease liabilities	111,300	120,437
Other liabilities	162,502	154,058
Total liabilities	3,091,558	2,906,095
Commitments and contingencies
Shareholders’ equity
Common shares, $1 par value Issued: 2023 — 48,046 shares; 2022 — 47,957 shares	48,046	47,957
Additional paid-in capital	749,712	715,118
Retained earnings	4,109,736	3,817,304
Accumulated other comprehensive loss	(314,405)	(403,522)
Shareholders equity before treasury stock, total	4,593,089	4,176,857
Less: Treasury stock, at cost	152,101	154,889
Total shareholders' equity	4,440,988	4,021,968
Total liabilities and shareholders' equity	$ 7,532,546	$ 6,928,063

About Teleflex Inc

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

CEO	Mr. Liam J. Kelly
WEBSITE	teleflex.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	15500

Teleflex Inc Frequently Asked Questions

What is the ticker symbol for Teleflex Inc? What does TFX stand for in stocks?

TFX is the stock ticker symbol of Teleflex Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Teleflex Inc (TFX)?

As of Mon Apr 15 2024, market cap of Teleflex Inc is 9.91 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TFX stock?

You can check TFX's fair value in chart for subscribers.

What is the fair value of TFX stock?

You can check TFX's fair value in chart for subscribers. The fair value of Teleflex Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Teleflex Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TFX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Teleflex Inc a good stock to buy?

The fair value guage provides a quick view whether TFX is over valued or under valued. Whether Teleflex Inc is cheap or expensive depends on the assumptions which impact Teleflex Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TFX.

What is Teleflex Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 15 2024, TFX's PE ratio (Price to Earnings) is 27.81 and Price to Sales (PS) ratio is 3.33. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TFX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Teleflex Inc's stock?

In the past 10 years, Teleflex Inc has provided 0.082 (multiply by 100 for percentage) rate of return.